Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3

Status

Completed 20Recruiting 8Terminated 7Active not recruiting 5Unknown 4Not yet recruiting 1

Sponsor Class

OTHER 13INDUSTRY 7

Study Type

Interventional 7

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Stomatitis 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Leukemia, Myeloid, Acute 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

pembrolizumab 184Carboplatin 130Paclitaxel 123Gemcitabine 122Docetaxel 96Cyclophosphamide 89Nivolumab 88Cisplatin 87Rituximab 71Dexamethasone 68Pemetrexed 64Bevacizumab 64Capecitabine 60atezolizumab 54fludarabine 49Azacitidine 49Fluorouracil 48130-nm albumin-bound paclitaxel 43venetoclax 41Trastuzumab 41Irinotecan 41Cetuximab 40Leucovorin 36Ipilimumab 36Erlotinib Hydrochloride 34Fulvestrant 32Cytarabine 32avelumab 31Oxaliplatin 31Albumin-Bound Paclitaxel 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Saline Solution × Clear all
NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT05163223 2024-06-17

Cornerstone001

Aston Sci. Inc.

Phase 2 Terminated
10 enrolled
Breast

Breast Neoplasms

NCT04571645 2024-04-15

AML

Jazz Pharmaceuticals

Phase 3 Terminated
9 enrolled 9 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01956812 2021-08-16

PANCRIT®-1

Gilead Sciences

Phase 3 Terminated
334 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01403064 2021-05-11

Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects

CSL Behring

Phase 2 Terminated
76 enrolled 25 charts
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT00738699 2017-03-30

FAR-122

Morphotek

Phase 2 Terminated
415 enrolled 11 charts
Gynecologic

Ovarian Neoplasms

NCT00850577 2015-10-12

Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer

Bristol-Myers Squibb

Phase 2 Terminated
255 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡